3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 25 0 1 0 0 0 0 0999 V2000
3.1163 1.3052 0.2423 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3664 -0.8738 -0.1702 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0884 -0.4610 -0.3575 C 0 0 2 0 0 0 0 0 0 0 0 0
-1.2696 -0.7988 0.2315 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1117 -1.5731 -0.1800 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7530 0.7455 0.3133 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2683 0.3709 0.1863 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2259 0.4780 0.1203 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5420 0.8485 -1.2405 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5819 -0.0415 0.8546 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0028 -0.2577 -1.4328 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.6867 -1.6625 -0.3027 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.1468 -1.1151 1.2759 H 0 0 0 0 0 0 0 0 0 0 0 0
1.0131 -2.0996 0.7747 H 0 0 0 0 0 0 0 0 0 0 0 0
1.0981 -2.2958 -1.0002 H 0 0 0 0 0 0 0 0 0 0 0 0
0.5495 0.7942 1.3882 H 0 0 0 0 0 0 0 0 0 0 0 0
0.4717 1.6867 -0.1664 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.8672 1.2161 0.7586 H 0 0 0 0 0 0 0 0 0 0 0 0
3.2655 -1.3247 -0.3069 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.8802 0.0238 -1.8769 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.6501 1.2887 -1.6957 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.3197 1.6201 -1.2483 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.0522 -0.8774 0.3254 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.2913 0.7928 0.8681 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.4112 -0.3493 1.8917 H 0 0 0 0 0 0 0 0 0 0 0 0
1 8 2 0 0 0 0
2 5 1 0 0 0 0
2 8 1 0 0 0 0
2 19 1 0 0 0 0
3 4 1 0 0 0 0
3 5 1 0 0 0 0
3 6 1 0 0 0 0
3 11 1 0 0 0 0
4 7 1 0 0 0 0
4 12 1 0 0 0 0
4 13 1 0 0 0 0
5 14 1 0 0 0 0
5 15 1 0 0 0 0
6 8 1 0 0 0 0
6 16 1 0 0 0 0
6 17 1 0 0 0 0
7 9 1 0 0 0 0
7 10 1 0 0 0 0
7 18 1 0 0 0 0
9 20 1 0 0 0 0
9 21 1 0 0 0 0
9 22 1 0 0 0 0
10 23 1 0 0 0 0
10 24 1 0 0 0 0
10 25 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
(4S)-4-(2-methylpropyl)pyrrolidin-2-one
4.2 InChl
InChI=1S/C8H15NO/c1-6(2)3-7-4-8(10)9-5-7/h6-7H,3-5H2,1-2H3,(H,9,10)/t7-/m0/s1
4.3 InChlKey
GUGXRXLTTHFKHC-ZETCQYMHSA-N
4.4 Canonical SMILES
CC(C)CC1CC(=O)NC1
4.5 lsomeric SMILES
CC(C)C[C@H]1CC(=O)NC1
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病